Hypothesis testing: CTLA4 co-stimulatory pathways critical in the pathogenesis of human and mouse alopecia areata.
作者信息
Sundberg John P, McElwee Kevin J, Carroll Joseph M, King Lloyd E
出版信息
J Invest Dermatol. 2011 Nov;131(11):2323-4. doi: 10.1038/jid.2011.203. Epub 2011 Jul 14.
Abstract
摘要
相似文献
1
Hypothesis testing: CTLA4 co-stimulatory pathways critical in the pathogenesis of human and mouse alopecia areata.
J Invest Dermatol. 2011 Nov;131(11):2323-4. doi: 10.1038/jid.2011.203. Epub 2011 Jul 14.
2
Cytotoxic T-lymphocyte antigen 4 (CTLA4) +49AG and CT60 gene polymorphisms in Alopecia Areata: a case-control association study in the Italian population.
Arch Dermatol Res. 2013 Sep;305(7):665-70. doi: 10.1007/s00403-013-1348-3. Epub 2013 Apr 9.
3
Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans.
J Invest Dermatol. 2002 Aug;119(2):392-402. doi: 10.1046/j.1523-1747.2002.01811.x.
4
Alopecia areata in aging C3H/HeJ mice.
J Invest Dermatol. 1994 Jun;102(6):847-56. doi: 10.1111/1523-1747.ep12382416.
5
CTLA4 +49AG (rs231775) and CT60 (rs3087243) gene variants are not associated with alopecia areata in a Mexican population from Monterrey Mexico.
An Bras Dermatol. 2020 May-Jun;95(3):283-288. doi: 10.1016/j.abd.2020.03.001. Epub 2020 Mar 20.
6
[Alopecia areata in animal models--new insights into pathogenesis and treatment of a T cell-mediated autoimmune disorder].
J Dtsch Dermatol Ges. 2004 Apr;2(4):260-73. doi: 10.1046/j.1610-0387.2003.03553.x-i1.
7
Association of Rs231775 Genetic Variant of Cytotoxic T-lymphocyte Associated Protein 4 with Alopecia Areata Disease in Males: A Case-Control Study.
Immunol Invest. 2021 Nov;50(8):977-986. doi: 10.1080/08820139.2020.1796700. Epub 2020 Jul 30.
8
Effect of PTPN22, FAS/FASL, IL2RA and CTLA4 genetic polymorphisms on the risk of developing alopecia areata: A systematic review of the literature and meta-analysis.
PLoS One. 2021 Nov 4;16(11):e0258499. doi: 10.1371/journal.pone.0258499. eCollection 2021.
9
Genetic variant association of PTPN22, CTLA4, IL2RA, as well as HLA frequencies in susceptibility to alopecia areata.
Immunol Invest. 2018 Oct;47(7):666-679. doi: 10.1080/08820139.2018.1480032. Epub 2018 Jul 6.
10
Genetic variants in CTLA4 are strongly associated with alopecia areata.
J Invest Dermatol. 2011 May;131(5):1169-72. doi: 10.1038/jid.2010.427. Epub 2011 Feb 24.
引用本文的文献
1
Recent advances in the genetics of alopecia areata.
Med Genet. 2023 Apr 5;35(1):15-22. doi: 10.1515/medgen-2023-2004. eCollection 2023 Apr.
2
Alopecia Areata: Review of Epidemiology, Clinical Features, Pathogenesis, and New Treatment Options.
Int J Trichology. 2018 Mar-Apr;10(2):51-60. doi: 10.4103/ijt.ijt_99_17.
3
Alopecia areata.
Nat Rev Dis Primers. 2017 Mar 16;3:17011. doi: 10.1038/nrdp.2017.11.
4
Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies.
Autoimmun Rev. 2016 Jul;15(7):726-35. doi: 10.1016/j.autrev.2016.03.008. Epub 2016 Mar 10.
5
The role of lymphocytes in the development and treatment of alopecia areata.
Expert Rev Clin Immunol. 2015;11(12):1335-51. doi: 10.1586/1744666X.2015.1085306. Epub 2015 Sep 7.
6
Alopecia areata: updates from the mouse perspective.
J Investig Dermatol Symp Proc. 2013 Dec;16(1):S23-4. doi: 10.1038/jidsymp.2013.6.
7
Surgical methods for full-thickness skin grafts to induce alopecia areata in C3H/HeJ mice.
Comp Med. 2013 Oct;63(5):392-7.
8
[Alopecia areata].
Hautarzt. 2013 Nov;64(11):806-9. doi: 10.1007/s00105-013-2576-3.
9
What causes alopecia areata?
Exp Dermatol. 2013 Sep;22(9):609-26. doi: 10.1111/exd.12209.
10
Genetic basis of alopecia areata: a roadmap for translational research.
Dermatol Clin. 2013 Jan;31(1):109-17. doi: 10.1016/j.det.2012.08.014. Epub 2012 Oct 23.
本文引用的文献
1
Genetic variants in CTLA4 are strongly associated with alopecia areata.
J Invest Dermatol. 2011 May;131(5):1169-72. doi: 10.1038/jid.2010.427. Epub 2011 Feb 24.
2
Anti-CTLA-4 antibody therapy: immune monitoring during clinical development of a novel immunotherapy.
Semin Oncol. 2010 Oct;37(5):473-84. doi: 10.1053/j.seminoncol.2010.09.001.
3
Genome-wide association study in alopecia areata implicates both innate and adaptive immunity.
Nature. 2010 Jul 1;466(7302):113-7. doi: 10.1038/nature09114.
4
Transcriptional profiling in alopecia areata defines immune and cell cycle control related genes within disease-specific signatures.
Genomics. 2010 Sep;96(3):146-53. doi: 10.1016/j.ygeno.2010.05.002. Epub 2010 May 28.
5
Can animal models of disease reliably inform human studies?
PLoS Med. 2010 Mar 30;7(3):e1000245. doi: 10.1371/journal.pmed.1000245.
6
Abatacept.
Br J Clin Pharmacol. 2009 Oct;68(4):480-1. doi: 10.1111/j.1365-2125.2009.03502.x.
7
One medicine, one pathology, and the one health concept.
J Am Vet Med Assoc. 2009 Jun 15;234(12):1530-1. doi: 10.2460/javma.234.12.1530.
8
The C3H/HeJ mouse and DEBR rat models for alopecia areata: review of preclinical drug screening approaches and results.
Exp Dermatol. 2008 Oct;17(10):793-805. doi: 10.1111/j.1600-0625.2008.00773.x.
9
Abatacept.
Nat Rev Drug Discov. 2006 Mar;5(3):185-6. doi: 10.1038/nrd1989.
10
Apoptosis resistance in peripheral blood lymphocytes of alopecia areata patients.
J Autoimmun. 2004 Nov;23(3):241-56. doi: 10.1016/j.jaut.2004.08.002.
Zotero 插件